Tiziana Life Sciences Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma
Tiziana Life Sci PLC (NASDAQ:TLSA LON:TILS) Dr Kunwar Shailubhai, CEO & CSO
Tiziana Reports Phase 2a Clinical Data with Milciclib Monotherapy in Sorafenib-refractory or -intolerant patients with unresectable or metastatic Hepatocellular Carcinoma.
Integumen PLC (LON:SKIN) CEO Gerry Brandon ‘ move into clinical trials.
Integumen PLC (LON:SKIN) CEO Gerry Brandon speaks to Proactive London’s Andrew Scott soon after announcing the roll-out of a new Labskin test designed to clone the skin of volunteers in clinical
WideCells Group PLC (LON:WDC) New Media Business Created
New Media Business Created, Board Appointments and Proposed Name Change to Iconic Labs Plc
WideCells Group PLC (AIM:WDC) Board Restructuring and Cost Cutting
The Group’s CEO, João Andrade, said, “I’d like to thank Alan Greenberg for his dedication to WideCells and I wish him all the best for the future.
4 Industries Set to Witness Massive Disruption from Blockchain
Photo: FM Blockchain technology is poised to revolutionize the way individuals live their daily lives The Internet has been an undeniably disruptive force causing massive shifts that have cut
